Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Wichmann

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Experimental Hematology|February 19, 2022
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiationEnric Redondo Monte, Georg Leubolt, Roland Windisch, et al.
Hemasphere|March 4, 2024
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockadeDenis M Schewe, Fotini Vogiatzi, Ira A Münnich, et al.
Plos Genetics|March 19, 2016
MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETONicole Kohrs, Stephan Kolodziej, Olga N Kuvardina, et al.
Archives of Toxicology|March 29, 2018
Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cellsMiriam Pons, Claudia M Reichardt, Dorle Hennig, et al.
Nature Neuroscience|September 14, 2023
A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis modelArek Kendirli, Clara de la Rosa, Katrin F Lämmle, et al.
Biological Chemistry|October 30, 2021
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigenChristian Kellner, Sebastian Lutz, Hans-Heinrich Oberg, et al.
Oncogene|March 3, 2020
ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cellsEnric Redondo Monte, Anja Wilding, Georg Leubolt, et al.
Cellular and Molecular Life Sciences : CMLS|July 11, 2024
CD74 is a functional MIF receptor on activated CD4<sup>+</sup> T cellsLin Zhang, Iris Woltering, Mathias Holzner, et al.
Haematologica|February 4, 2017
Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerizationJulia Schanda, Chun-Wei Lee, Katharina Wohlan, et al.
BMJ Open|November 18, 2022
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with <sup>89</sup>Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocolFiona Hegi-Johnson, Stacey E Rudd, Christian Wichmann, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Experimental Hematology|February 19, 2022
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiationEnric Redondo Monte, Georg Leubolt, Roland Windisch, et al.
Hemasphere|March 4, 2024
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockadeDenis M Schewe, Fotini Vogiatzi, Ira A Münnich, et al.
Plos Genetics|March 19, 2016
MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETONicole Kohrs, Stephan Kolodziej, Olga N Kuvardina, et al.
Archives of Toxicology|March 29, 2018
Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cellsMiriam Pons, Claudia M Reichardt, Dorle Hennig, et al.
Nature Neuroscience|September 14, 2023
A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis modelArek Kendirli, Clara de la Rosa, Katrin F Lämmle, et al.
Biological Chemistry|October 30, 2021
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigenChristian Kellner, Sebastian Lutz, Hans-Heinrich Oberg, et al.
Oncogene|March 3, 2020
ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cellsEnric Redondo Monte, Anja Wilding, Georg Leubolt, et al.
Cellular and Molecular Life Sciences : CMLS|July 11, 2024
CD74 is a functional MIF receptor on activated CD4<sup>+</sup> T cellsLin Zhang, Iris Woltering, Mathias Holzner, et al.
Haematologica|February 4, 2017
Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerizationJulia Schanda, Chun-Wei Lee, Katharina Wohlan, et al.
BMJ Open|November 18, 2022
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with <sup>89</sup>Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocolFiona Hegi-Johnson, Stacey E Rudd, Christian Wichmann, et al.
Pageof 6